Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

417.3000 -4.70 (-1.11%)

NSE Dec 26, 2025 15:31 PM

26.02% Fall from 52W High

Volume: 159.1K

Aarti Drugs Ltd.

30 Oct 2022

417.30

-1.11%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

Aarti Drugs could be benefitted in upcoming quarters, we upgrade to BUY on Aarti Drugs with Target Price of Rs 545

Aarti Drugs Ltd. has an average target of 610.00 from 1 broker.